Icosavax, Inc. is a Seattle, Washington-based clinical-stage biopharmaceutical company specializing in developing novel vaccines utilizing virus-like particle technology.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Icosavax, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Icosavax, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.